X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2017) 2017
Publication (158) 158
Book Review (35) 35
Magazine Article (25) 25
Book Chapter (19) 19
Trade Publication Article (11) 11
Newsletter (9) 9
Conference Proceeding (3) 3
Data Set (2) 2
Book / eBook (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
dabigatran (1483) 1483
humans (1351) 1351
index medicus (1338) 1338
warfarin (892) 892
anticoagulants (861) 861
rivaroxaban (834) 834
pharmacology & pharmacy (760) 760
dabigatran etexilate (623) 623
atrial fibrillation (609) 609
apixaban (540) 540
anticoagulants - therapeutic use (535) 535
administration, oral (498) 498
stroke (446) 446
male (440) 440
venous thromboembolism (421) 421
anticoagulants - adverse effects (400) 400
female (393) 393
atrial fibrillation - drug therapy (386) 386
atrial-fibrillation (379) 379
anticoagulants - administration & dosage (376) 376
prevention (368) 368
aged (348) 348
anticoagulants - pharmacology (336) 336
thromboembolism (316) 316
beta-alanine - analogs & derivatives (307) 307
stroke - prevention & control (287) 287
hemorrhage - chemically induced (284) 284
thrombin (278) 278
direct thrombin inhibitor (276) 276
hematology (270) 270
middle aged (253) 253
risk factors (249) 249
benzimidazoles - therapeutic use (241) 241
medicine & public health (241) 241
cardiac & cardiovascular systems (237) 237
stroke prevention (228) 228
drug therapy (226) 226
safety (223) 223
peripheral vascular disease (222) 222
blood coagulation - drug effects (221) 221
analysis (218) 218
pharmacokinetics (218) 218
atrial fibrillation - complications (214) 214
oral anticoagulants (208) 208
treatment outcome (208) 208
management (203) 203
animals (202) 202
pharmacology (201) 201
dosage and administration (199) 199
bleeding (197) 197
anticoagulation (196) 196
benzimidazoles - pharmacology (196) 196
cardiac arrhythmia (195) 195
warfarin - therapeutic use (193) 193
risk (184) 184
therapy (182) 182
benzimidazoles - adverse effects (181) 181
care and treatment (178) 178
aged, 80 and over (177) 177
thrombosis (171) 171
factor xa inhibitors (168) 168
double-blind (165) 165
hemorrhage (164) 164
edoxaban (163) 163
cardiology (162) 162
pyrazoles - therapeutic use (161) 161
pyridones - therapeutic use (161) 161
antithrombins - pharmacology (160) 160
pyridines - therapeutic use (155) 155
antithrombins - therapeutic use (154) 154
benzimidazoles - administration & dosage (153) 153
antithrombins - adverse effects (150) 150
internal medicine (149) 149
dabigatran - therapeutic use (148) 148
pharmacodynamics (148) 148
patients (146) 146
research (144) 144
stroke - etiology (140) 140
thrombin - antagonists & inhibitors (140) 140
adult (138) 138
factor-xa inhibitor (136) 136
enoxaparin (134) 134
factor xa inhibitor (134) 134
pharmacology/toxicology (134) 134
beta-alanine - therapeutic use (130) 130
etexilate (130) 130
vitamin k - antagonists & inhibitors (129) 129
anticoagulants - pharmacokinetics (127) 127
thiophenes - therapeutic use (127) 127
drug interactions (126) 126
morpholines - therapeutic use (125) 125
dose-response relationship, drug (124) 124
dabigatran - adverse effects (123) 123
dabigatran - pharmacology (123) 123
efficacy (123) 123
usage (122) 122
venous thromboembolism - prevention & control (122) 122
antithrombotic therapy (121) 121
deep-vein thrombosis (119) 119
beta-alanine - adverse effects (115) 115
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1969) 1969
French (26) 26
German (23) 23
Spanish (20) 20
Russian (8) 8
Japanese (5) 5
Hungarian (4) 4
Slovenian (4) 4
Danish (3) 3
Polish (2) 2
Arabic (1) 1
Norwegian (1) 1
Portuguese (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Heart Journal, ISSN 0195-668X, 2013, Volume 34, Issue 23, pp. 1708 - 13, 1713a-1713b
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2014, Volume 64, Issue 11, pp. 1128 - 1139
Abstract Background Non–vitamin K oral anticoagulants (NOACs) do not require routine laboratory monitoring. However, laboratory measurement may be desirable in... 
Cardiovascular | Internal Medicine | dabigatran | rivaroxaban | monitoring | laboratory | apixaban | MEASURING RIVAROXABAN | CARDIAC & CARDIOVASCULAR SYSTEMS | DIRECT THROMBIN INHIBITOR | DABIGATRAN CONCENTRATIONS | PROTHROMBIN TIME | PARTIAL THROMBOPLASTIN TIME | COAGULATION ASSAYS | IN-VITRO | FACTOR-XA INHIBITOR | PLASMA-CONCENTRATIONS | INTERNATIONAL NORMALIZED RATIO | Anticoagulants - administration & dosage | Humans | Antithrombins - administration & dosage | Thiophenes - administration & dosage | Dabigatran | Factor Xa Inhibitors - administration & dosage | Antithrombins - pharmacology | Pyridones - administration & dosage | Rivaroxaban | Benzimidazoles - administration & dosage | beta-Alanine - pharmacology | Factor Xa Inhibitors - pharmacology | beta-Alanine - analogs & derivatives | Pyrazoles - pharmacology | Administration, Oral | Morpholines - administration & dosage | beta-Alanine - administration & dosage | Morpholines - pharmacology | Thiophenes - pharmacology | Pyrazoles - administration & dosage | Partial Thromboplastin Time | Anticoagulants - pharmacology | Benzimidazoles - pharmacology | Drug Monitoring | Pyridones - pharmacology | Measurement | Anticoagulants (Medicine) | Vitamins | Studies | Anticoagulants | Plasma | Bibliographic literature | Laboratories | Drug therapy | Drug dosages | Bone surgery
Journal Article
THROMBOSIS AND HAEMOSTASIS, ISSN 0340-6245, 09/2016, Volume 116, Issue 3, pp. 461 - 471
Venous thromboembolism (VTE) incidence is increasing among children owing to many factors, including improved diagnosis of VIE. There is a need for alternative... 
POPULATION | RE-LY TRIAL | THROMBOSIS | MATURATION | CHILDHOOD | ATRIAL-FIBRILLATION | CHILDREN | WARFARIN | venous thromboembolism | Adolescent | PEDIATRIC-PATIENTS | anticoagulants | dabigatran | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | direct thrombin inhibitors | Direct thrombin inhibitors | Anticoagulants | Dabigatran | Venous thromboembolism
Journal Article
Journal Article
European Heart Journal, ISSN 0195-668X, 02/2013, Volume 34, Issue 7, pp. 489 - 500
Novel oral anticoagulants that directly inhibit thrombin (dabigatran) or factor Xa (rivaroxaban, apixaban) are currently available for prevention of venous... 
Novel oral anticoagulants | Bleeding | Management | RECOMBINANT FACTOR-VIIA | CARDIAC & CARDIOVASCULAR SYSTEMS | DIRECT THROMBIN INHIBITOR | RANDOMIZED EVALUATION | INTRACRANIAL HEMORRHAGE | ACTIVATED FACTOR-VII | FACTOR-XA INHIBITOR | DABIGATRAN ETEXILATE | VENOUS THROMBOEMBOLISM | PROTHROMBIN COMPLEX CONCENTRATE | NONVALVULAR ATRIAL-FIBRILLATION | Plasma | Anticoagulants - administration & dosage | Factor Xa Inhibitors | Thiophenes - adverse effects | Humans | Antithrombins - administration & dosage | Hemorrhage - prevention & control | Thiophenes - administration & dosage | Dabigatran | Antithrombins - pharmacology | Pyridones - administration & dosage | Rivaroxaban | Benzimidazoles - administration & dosage | Platelet Aggregation Inhibitors - administration & dosage | beta-Alanine - pharmacology | Renal Insufficiency - complications | Benzimidazoles - adverse effects | Drug Therapy, Combination | beta-Alanine - analogs & derivatives | Morpholines - adverse effects | Pyrazoles - adverse effects | Pyrazoles - pharmacology | Acute Disease | beta-Alanine - adverse effects | Administration, Oral | Morpholines - administration & dosage | Risk Factors | beta-Alanine - administration & dosage | Morpholines - pharmacology | Thiophenes - pharmacology | Anticoagulants - adverse effects | Pyrazoles - administration & dosage | Anticoagulants - pharmacology | Antithrombins - adverse effects | Blood Coagulation Tests | Benzimidazoles - pharmacology | Aged | Hemostatics - therapeutic use | Pyridones - adverse effects | Pyridones - pharmacology | Renal Dialysis
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 08/2010, Volume 104, Issue 2, pp. 302 - 310
Journal Article
Journal Article
Journal Article
Journal Article
American Journal of Hypertension, ISSN 0895-7061, 2/2015, Volume 28, Issue 2, pp. 182 - 189
Journal Article